Danaher Corporation (DHR)

NYSE Health Care Life Sciences Tools & Services S&P 500

$230.25

+3.91 (+1.73%)

Close of Nov 06, 2026 · end-of-day data

Source: Danaher Corporation's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 04, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$16.88B	$15.52B	$17.05B	$17.91B	$22.28B	$24.80B	$26.64B	$23.89B	$23.88B	$24.57B
Cost of revenue	$7.55B	$6.95B	$7.54B	$7.93B	$9.81B	$9.56B	$10.46B	$9.86B	$9.67B	$10.04B
Gross profit	$9.33B	$8.57B	$9.51B	$9.98B	$12.47B	$15.24B	$16.19B	$14.03B	$14.21B	$14.52B
Research & development	$975.10M	$956.40M	$1.06B	$1.13B	$1.35B	$1.50B	$1.53B	$1.50B	$1.58B	$1.60B
Selling, general & admin	$5.62B	$5.04B	$5.39B	$5.59B	$6.90B	$6.82B	$7.12B	$7.33B	$7.76B	$8.23B
Operating income	$2.74B	$2.57B	$3.06B	$3.27B	$4.23B	$6.38B	$7.54B	$5.20B	$4.86B	$4.69B
Interest expense	$184.40M	$140.10M	$137.00M	$108.00M	$275.00M	$231.00M	$204.00M	$286.00M	$278.00M	$265.00M
Pre-tax income	$2.61B	$2.54B	$2.96B	$3.31B	$4.50B	$6.51B	$7.15B	$5.04B	$4.65B	$4.23B
Income tax	$457.90M	$371.00M	$556.00M	$873.00M	$849.00M	$1.06B	$818.00M	$823.00M	$747.00M	$633.00M
Net income	$2.55B	$2.49B	$2.65B	$3.01B	$3.65B	$6.43B	$7.21B	$4.76B	$3.90B	$3.61B
EBITDA	$3.86B	$3.69B	$4.23B	$4.46B	$6.01B	$8.44B	$9.67B	$7.37B	$5.58B	$5.44B
EPS (basic)	$3.69	$3.58	$3.78	$4.11	$4.97	$8.77	$9.80	$6.44	$5.33	$5.07
EPS (diluted)	$3.65	$3.53	$3.74	$4.05	$4.89	$8.61	$9.66	$6.38	$5.29	$5.05
Diluted shares	699.80M	706.10M	710.20M	725.50M	718.70M	736.80M	737.10M	743.10M	737.20M	716.10M
Gross margin	55.3%	55.2%	55.8%	55.7%	56.0%	61.4%	60.8%	58.7%	59.5%	59.1%
Operating margin	16.2%	16.6%	17.9%	18.3%	19.0%	25.7%	28.3%	21.8%	20.4%	19.1%
Net margin	15.1%	16.1%	15.5%	16.8%	16.4%	25.9%	27.1%	19.9%	16.3%	14.7%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$963.70M	$630.30M	$787.80M	$19.91B	$6.04B	$2.59B	$6.00B	$5.86B	$2.08B	$4.62B
Receivables	$3.19B	$3.52B	$3.03B	$3.19B	$4.04B	$4.63B	$4.10B	$3.92B	$3.54B	$3.91B
Inventory	$1.71B	$1.84B	$1.63B	$1.63B	$2.29B	$2.77B	$2.77B	$2.59B	$2.33B	$2.49B
Total current assets	$6.67B	$6.85B	$7.09B	$25.60B	$13.80B	$11.65B	$15.88B	$13.94B	$9.50B	$12.76B
Goodwill	$23.83B	$21.77B	$22.58B	$22.71B	$35.42B	$38.68B	$37.28B	$41.61B	$40.50B	$43.15B
Total assets	$45.30B	$46.65B	$47.83B	$62.08B	$76.16B	$83.18B	$84.35B	$84.49B	$77.54B	$83.46B
Total current liabilities	$6.87B	$4.79B	$4.84B	$4.93B	$7.40B	$8.14B	$8.39B	$8.27B	$6.80B	$6.81B
Short-term debt	$2.59B	$194.70M	$51.80M	$212.00M	$11.00M	$8.00M	$591.00M	$1.70B	$505.00M	$2.00M
Long-term debt	$9.67B	$10.33B	$9.69B	$21.52B	$21.19B	$22.17B	$19.09B	$16.71B	$15.50B	$18.42B
Total debt	$12.27B	$10.52B	$9.74B	$21.73B	$21.20B	$22.18B	$19.68B	$18.40B	$16.00B	$18.42B
Total liabilities	$22.29B	$20.29B	$19.62B	$31.81B	$36.40B	$38.02B	$34.27B	$31.00B	$28.00B	$30.93B
Shareholders' equity	$23.00B	$26.36B	$28.21B	$30.27B	$39.77B	$45.17B	$50.08B	$53.49B	$49.54B	$52.53B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$3.52B	$3.48B	$4.02B	$3.95B	$6.21B	$8.36B	$8.52B	$7.16B	$6.69B	$6.42B
Capital expenditures	$589.60M	$570.70M	$584.00M	$636.00M	$791.00M	$1.24B	$1.12B	$1.38B	$1.39B	$1.16B
Free cash flow	$2.93B	$2.91B	$3.44B	$3.32B	$5.42B	$7.12B	$7.40B	$5.78B	$5.30B	$5.26B
Investing cash flow	-$5.24B	-$843.40M	-$2.95B	-$1.24B	-$21.24B	-$12.99B	-$2.23B	-$7.08B	-$1.98B	-$1.20B
Financing cash flow	$2.04B	-$3.10B	-$797.00M	$16.36B	$1.01B	$1.29B	-$2.57B	-$273.00M	-$8.38B	-$2.96B
Dividends paid	$399.80M	$378.30M	$433.00M	$527.00M	$615.00M	$742.00M	$818.00M	$821.00M	$768.00M	$878.00M
Share buybacks	—	—	—	—	—	—	$0	$0	$5.98B	$3.09B
Stock-based compensation	$129.80M	$127.10M	$138.00M	$159.00M	$187.00M	$184.00M	$295.00M	$306.00M	$288.00M	$298.00M
Depreciation & amortization	$1.13B	$1.12B	$1.18B	$1.19B	$1.77B	$2.06B	$2.13B	$2.17B	$721.00M	$750.00M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$6.41B	$5.80B	$5.74B	$5.80B	$6.54B	$5.74B	$5.94B	$6.05B	$6.84B	$5.95B	$6.26B	$6.55B
Cost of revenue	$2.63B	$2.31B	$2.31B	$2.40B	$2.65B	$2.23B	$2.41B	$2.53B	$2.87B	$2.36B	$2.65B	$2.72B
Gross profit	$3.78B	$3.49B	$3.43B	$3.40B	$3.89B	$3.51B	$3.52B	$3.52B	$3.97B	$3.59B	$3.61B	$3.84B
Research & development	$407.00M	$368.00M	$391.00M	$383.00M	$442.00M	$379.00M	$403.00M	$378.00M	$438.00M	$387.00M	$412.00M	$433.00M
Selling, general & admin	$2.04B	$1.81B	$1.87B	$2.06B	$2.02B	$1.86B	$2.36B	$1.99B	$2.03B	$1.86B	$2.07B	$2.16B
Operating income	$1.34B	$1.31B	$1.17B	$958.00M	$1.43B	$1.27B	$760.00M	$1.15B	$1.50B	$1.34B	$1.13B	$1.25B
Interest expense	$78.00M	$65.00M	$65.00M	$87.00M	$61.00M	$72.00M	$71.00M	$67.00M	$55.00M	$63.00M	$107.00M	$135.00M
Pre-tax income	$1.23B	$1.27B	$1.08B	$977.00M	$1.31B	$1.13B	$655.00M	$1.08B	$1.37B	$1.24B	$1.08B	$1.13B
Income tax	$111.00M	$183.00M	$176.00M	$159.00M	$229.00M	$175.00M	$100.00M	$168.00M	$190.00M	$206.00M	$208.00M	-$75.00M
Net income	$1.08B	$1.09B	$907.00M	$818.00M	$1.09B	$954.00M	$555.00M	$908.00M	$1.20B	$1.03B	$870.00M	$1.24B
EBITDA	$1.51B	$1.49B	$1.35B	$1.14B	$1.61B	$1.46B	$945.00M	$1.34B	$1.70B	$1.54B	$1.32B	$1.45B
EPS (basic)	$1.46	$1.47	$1.23	$1.13	$1.50	$1.33	$0.77	$1.28	$1.69	$1.45	$1.23	$1.75
EPS (diluted)	$1.45	$1.45	$1.22	$1.12	$1.49	$1.32	$0.77	$1.27	$1.68	$1.45	$1.23	$1.75
Diluted shares	1.00M	748.60M	742.40M	729.40M	-2.90M	720.80M	719.10M	713.70M	-1.80M	711.20M	707.60M	706.80M
Gross margin	59.0%	60.2%	59.7%	58.7%	59.5%	61.2%	59.3%	58.2%	58.0%	60.3%	57.6%	58.5%
Operating margin	20.9%	22.6%	20.3%	16.5%	21.8%	22.2%	12.8%	19.1%	22.0%	22.6%	18.0%	19.0%
Net margin	16.8%	18.8%	15.8%	14.1%	16.6%	16.6%	9.3%	15.0%	17.5%	17.3%	13.9%	18.8%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$5.86B	$7.03B	$2.37B	$2.63B	$2.08B	$1.99B	$2.96B	$1.53B	$4.62B	$5.70B	$4.35B	$5.68B
Receivables	$3.92B	$3.38B	$3.30B	$3.51B	$3.54B	$3.51B	$3.56B	$3.75B	$3.91B	$3.82B	$3.96B	$4.13B
Inventory	$2.59B	$2.65B	$2.67B	$2.68B	$2.33B	$2.53B	$2.69B	$2.67B	$2.49B	$2.61B	$3.26B	$3.13B
Total current assets	$13.94B	$14.37B	$9.61B	$10.06B	$9.50B	$9.53B	$11.00B	$9.61B	$12.76B	$13.94B	$13.38B	$14.79B
Goodwill	$41.61B	$40.85B	$40.80B	$42.17B	$40.50B	$41.66B	$42.99B	$42.95B	$43.15B	$42.77B	$47.41B	$47.31B
Total assets	$84.49B	$83.40B	$78.56B	$80.61B	$77.54B	$79.12B	$81.62B	$79.90B	$83.46B	$83.54B	$92.37B	$93.28B
Total current liabilities	$8.27B	$7.78B	$6.70B	$7.34B	$6.80B	$6.64B	$6.79B	$6.32B	$6.81B	$7.46B	$8.11B	$9.05B
Short-term debt	$1.70B	$1.75B	$701.00M	$1.20B	$505.00M	$501.00M	$502.00M	$23.00M	$2.00M	$923.00M	$1.41B	$2.09B
Long-term debt	$16.71B	$16.42B	$16.31B	$16.32B	$15.50B	$15.98B	$16.85B	$16.83B	$18.42B	$17.56B	$25.15B	$24.39B
Total debt	$18.40B	$18.16B	$17.01B	$17.52B	$16.00B	$16.48B	$17.36B	$16.86B	$18.42B	$18.48B	$26.56B	$26.48B
Total liabilities	$31.00B	$29.96B	$28.66B	$29.32B	$28.00B	$28.27B	$29.29B	$28.83B	$30.93B	$30.59B	$39.79B	$39.66B
Shareholders' equity	$53.49B	$53.44B	$49.90B	$51.30B	$49.54B	$50.85B	$52.33B	$51.07B	$52.53B	$52.95B	$52.58B	$53.62B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$1.62B	$1.74B	$1.42B	$1.51B	$2.02B	$1.30B	$1.34B	$1.66B	$2.12B	$1.32B	$1.53B	$1.89B
Capital expenditures	$434.00M	$291.00M	$287.00M	$298.00M	$516.00M	$245.00M	$248.00M	$292.00M	$371.00M	$237.00M	$269.00M	$255.00M
Free cash flow	$1.19B	$1.45B	$1.13B	$1.22B	$1.50B	$1.05B	$1.09B	$1.37B	$1.75B	$1.08B	$1.26B	$1.63B
Investing cash flow	-$6.02B	-$321.00M	-$360.00M	-$606.00M	-$694.00M	-$242.00M	-$258.00M	-$312.00M	-$384.00M	-$249.00M	-$10.15B	-$300.00M
Financing cash flow	-$2.25B	-$133.00M	-$5.71B	-$845.00M	-$1.69B	-$1.25B	-$247.00M	-$2.78B	$1.32B	$46.00M	$7.27B	-$262.00M
Dividends paid	$200.00M	$177.00M	$200.00M	$196.00M	$195.00M	$194.00M	$229.00M	$229.00M	$226.00M	$226.00M	$283.00M	$281.00M
Share buybacks	$0	$0	$4.53B	$640.00M	$809.00M	$1.08B	$0	$2.01B	$0	$0	$894.00M	$0
Stock-based compensation	$61.00M	$60.00M	$87.00M	$84.00M	$57.00M	$61.00M	$91.00M	$83.00M	$63.00M	$58.00M	$93.00M	$115.00M
Depreciation & amortization	$178.00M	$179.00M	$178.00M	$177.00M	$187.00M	$181.00M	$185.00M	$189.00M	$195.00M	$193.00M	$196.00M	$208.00M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.